Stay updated on Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the only other deletion is a minor UI element ('Back to Top') and does not affect core content.
    Difference
    0.1%
    Check dated 2025-09-14T00:11:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T21:09:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and locations, as well as additional resources related to various cancers, while removing outdated location terms and some specific cancer resources. Notably, the names of drugs such as dabrafenib and trametinib have been added, indicating a focus on recent advancements in cancer treatment.
    Difference
    6%
    Check dated 2025-08-30T15:31:05.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.5%
    Check dated 2025-08-23T14:09:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.2%
    Check dated 2025-08-16T12:06:19.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.2%
    Check dated 2025-08-09T07:34:49.000Z thumbnail image

Stay in the know with updates to Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dabrafenib/Trametinib in BRAF V600E+ Rare Cancers Clinical Trial page.